Skip to main content

TELA Bio, Inc.

corporate_fare Company Profile

TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed TELA - Latest Insights

TELA
Mar 25, 2026, 4:05 PM EDT
Filing Type: 10-K
Importance Score:
9
TELA
Mar 24, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
TELA
Mar 24, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
TELA
Mar 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9